Head-to-head
Mochi Health vs Ivim Health
Compared on both medications across the eight dimensions this database records. They differ on 5 of those eight. Ivim Health is cheaper on all-in tirzepatide at 10 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.
The short answer
Mochi Health is $357 a month all-in for tirzepatide; Ivim Health is $353. Over twelve months that is $4,284 against $4,236. Value Scores are 55.9 and 46.3 out of 100.
Tirzepatide
Plan pages: Mochi Health plans · Ivim Health plans
At 10 mg/week, Mochi Health is $357 a month all-in and Ivim Health is $353 — $4 apart, or $48 across a year. Over twelve months the totals are $4,284 (billed monthly) and $4,236 (billed monthly).
Mochi Health charges a flat $278 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay.
Ivim Health prices tirzepatide by dose: $208 per month at 2.5 mg rising to $278 at 10 mg, a difference of $70 a month between the bottom and top of the ladder. The company publishes no price at 5, 7.5, 12.5, 15 mg, so those doses are left blank rather than estimated.
| Dose | Mochi Health | Rank | Ivim Health | Rank | Cheaper |
|---|---|---|---|---|---|
| 2.5 mg | $278 | 14/31 | $208 | 10/31 | Ivim Health by $70 |
| 5 mg | $278 | 7/17 | — | — | only Mochi Health publishes |
| 7.5 mg | $278 | 7/17 | — | — | only Mochi Health publishes |
| 10 mg | $278 | 8/27 | $278 | 7/27 | level |
| 12.5 mg | $278 | 7/17 | — | — | only Mochi Health publishes |
| 15 mg | $278 | 7/17 | — | — | only Mochi Health publishes |
The lead changes with the dose. Between 2.5 mg and 10 mg it passes to Mochi Health. Pick on the dose you expect to settle at, not the headline.
Across the 27 programs this database can rank on tirzepatide, Mochi Health sits 17 of 27 on all-in monthly cost and Ivim Health sits 16. They are adjacent in the field, with nothing priced between them. The field median is $339 and the floor is $169, so both sit above the median. Mochi Health is $188 above the cheapest tirzepatide program on record. Ivim Health is $184 above the cheapest tirzepatide program on record.
LillyDirect (Zepbound), the lowest FDA-approved tirzepatide channel here, is $449 a month — Mochi Health undercuts it by $92, Ivim Health by $96. Compounded products are not FDA approved; insurance can reverse that comparison.
| Plan term | Mochi Health | Ivim Health | Cheaper |
|---|---|---|---|
| Month to month | $278 | $278 | level |
| Settled dose | Mochi Health | Ivim Health | Difference |
|---|---|---|---|
| 2.5 mg | $4,284 | $3,396 | $888 apart |
| 5 mg | $4,284 | — | one side unpriced |
| 7.5 mg | $4,284 | — | one side unpriced |
| 10 mg | $4,284 | $4,236 | $48 apart |
| 12.5 mg | $4,284 | — | one side unpriced |
| 15 mg | $4,284 | — | one side unpriced |
Mochi Health publishes no rate for 3-month term, 6-month term, 12-month term; Ivim Health publishes none for 3-month term, 6-month term, 12-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.
A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 10 mg/week, the first twelve months work out to $4,284 on Mochi Health and $4,166 on Ivim Health — $118 apart, and a different gap from the $48 you would get by multiplying the monthly difference by twelve. The ramp is cheaper than the settled rate on whichever program prices by dose, which is why a first-year quote and a steady-state quote are not the same number.
That calculation is partial: Ivim Health publishes no price at 2 of them, so the maintenance rate stands in for the missing steps rather than a number the company has stated.
Value Scores are 55.9 for Mochi Health and 46.3 for Ivim Health, against a tirzepatide category floor of $169. Mochi Health leads by 9.6 points, and the margin comes from structure rather than price alone.
| Program | Price /70 | Evidence /15 | Dose /10 | Membership /5 | Total /100 |
|---|---|---|---|---|---|
| Mochi Health | 33.1 | 12.8 | 10 | 0 | 55.9 |
| Ivim Health | 33.5 | 12.8 | 0 | 0 | 46.3 |
Semaglutide
Plan pages: Mochi Health plans · Ivim Health plans
At 2.4 mg/week, Mochi Health is $257 a month all-in and Ivim Health is $224 — $33 apart, or $396 across a year. Over twelve months the totals are $3,084 (billed monthly) and $2,688 (billed monthly).
Mochi Health charges a flat $178 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
Ivim Health charges a flat $149 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay. The company publishes no price at 0.5, 1, 1.7 mg, so those doses are left blank rather than estimated.
Ivim Health is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Value Scores are 57.9 for Mochi Health and 53.1 for Ivim Health, against a semaglutide category floor of $129. Mochi Health leads by 4.8 points, driven mostly by price.
Where the two programs differ
All-in monthly
Ivim Health is cheaper month to month — $353 against $357, a gap of $4 every month, or $48 across a year if both rates hold.
Cancellation terms
Cancellation differs: Mochi Health states Cancel anytime before renewal, while Ivim Health states Cancel anytime. Read this next to the twelve-month figures — a prepaid discount and a restrictive refund policy are the same decision.
Dose policy
Mochi Health charges one price at every dose; Ivim Health prices by dose. That difference usually matters more than the headline gap, because the tiered program's advertised figure describes the dose you start on, not the dose you settle at.
Membership fee
Mochi Health charges a membership of $79 a month on top of the medication. That is already folded into the all-in figures above — it is broken out here because a membership is a recurring charge that continues even in a month you skip a shipment.
Twelve-month cost
Over twelve months the totals are $4,284 for Mochi Health and $4,236 for Ivim Health. Ivim Health is lower by $48 — a figure worth checking against the cancellation terms below, because a prepaid year is only cheaper if you stay on it.
Commitment
Commitment terms read the same on both: Month-to-month.
Evidence status
Both figures carry the same evidence status, provider-stated: taken from the provider's own published pages; checkout capture pending. Neither is stronger than the other on provenance.
Shipping
Shipping is handled the same way by both — included in the quoted price.
What each record says
Mochi Health Official site
Mochi separates a $79/month clinical membership ($39 first month in some states) from flat medication pricing — $99/month semaglutide at any dose and $199/month tirzepatide at any dose — which makes its all-in cost easy to compute and its structure one of the most transparent in the category.
It names its compounding pharmacy — Partner 503A/503B pharmacies, recorded as Partner network — which can be checked against state board licensing and FDA inspection records before you order; commitment terms are Month-to-month; cancellation is Cancel anytime before renewal; availability is stated as ~50 states.
Evidence: provider-stated — taken from the provider's own published pages; checkout capture pending, captured . Source — joinmochi.com pricing + FAQ captures 2026-07-20 and 2026-08-05
Watch: Advertising leads with the medication price; the $79 membership is the number people miss. Eli Lilly named Mochi in 2025 personalized-dosing litigation; the company continues to operate.
Ivim Health Official site
Ivim combines a $75/month membership with tiered medication pricing; its all-in semaglutide figure ($149) is competitive, while tirzepatide lands mid-pack at $278 all-in at the 10 mg basis.
It does not publicly name its compounding pharmacy; the record shows Partner pharmacies, so who actually makes the medication cannot be independently verified; commitment terms are Month-to-month; cancellation is Cancel anytime; availability is stated as ~50 states.
Evidence: provider-stated — taken from the provider's own published pages; checkout capture pending, captured . Source — ivimhealth.com pricing captures 2026-08-05
Watch: Dose-tiered tirzepatide means the advertised start price understates maintenance cost; compare on the maintenance column.
What neither record tells you
Mochi Health does not publish
- no published twelve-month tirzepatide rate
- no published twelve-month semaglutide rate
- no state-by-state availability list — it says ~50 states
Ivim Health does not publish
- no tirzepatide price at 5, 7.5, 12.5, 15 mg per week
- no published twelve-month tirzepatide rate
- no semaglutide price at 0.5, 1, 1.7 mg per week
- no published twelve-month semaglutide rate
- no named compounding pharmacy
- no state-by-state availability list — it says ~50 states
Ask Mochi Health and Ivim Health for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.
What would change this answer
Neither program publishes a promotional rate with an end date, a prepaid term, or a price we have flagged for re-verification, so the comparison above is as stable as this dataset gets.
Which one suits which reader
On the lowest standing monthly rate for tirzepatide, Ivim Health Official site wins this matchup. If you expect to titrate to the top of the ladder, mochi health's flat pricing is worth more than the headline gap suggests; if you want to be able to pause without still paying, ivim health carries no membership.
Both figures should be checked at the provider's own checkout before you pay. Mochi Health's tirzepatide price is provider-stated as of 2026-08-05; Ivim Health's is provider-stated as of 2026-08-05.
Questions
Is Mochi Health or Ivim Health cheaper for tirzepatide?
Ivim Health is cheaper on all-in monthly cost at 10 mg/week: $353 against $357, a difference of $4 a month. All-in means the medication plus every mandatory recurring fee.
What is the twelve-month cost of Mochi Health versus Ivim Health?
Mochi Health works out to $4,284 across twelve months and Ivim Health to $4,236, on the plan terms each publishes.
Does Mochi Health or Ivim Health raise the price as the dose goes up?
Mochi Health: no, it charges one flat rate at every dose. Ivim Health: yes, it prices by dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.
How many ways do Mochi Health and Ivim Health differ?
5 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.
Which of Mochi Health and Ivim Health names its pharmacy?
Mochi Health does — Partner 503A/503B pharmacies. Ivim Health does not, recording only Partner pharmacies, so who makes its medication cannot be independently verified.
How well evidenced are the Mochi Health and Ivim Health prices?
Mochi Health's tirzepatide figure is provider-stated — taken from the provider's own published pages; checkout capture pending — captured 2026-08-05. Ivim Health's is provider-stated, captured 2026-08-05. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.
Which is cheaper for semaglutide?
Ivim Health, at $224 a month all-in against $257 at 2.4 mg/week. The two programs do not necessarily lead on both medications.
Official sources: Mochi Health official site · Ivim Health official site. Compounded tirzepatide and semaglutide are not FDA-approved products.